News

4DMT Presents Positive Interim Data from Randomized Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 Demonstrating Favorable Tolerability & Clinical Activity in Wet AMD

51 wet AMD patients with severe disease activity (mean of 442 µm central subfield thickness & presence of retinal fluid)…

7 months ago

EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration

Subgroup analyses underscore favorable clinical profile and durability of EYP-1901Presentations highlight previously reported positive Phase 2 DAVIO 2 topline results…

7 months ago

Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

SAN CARLOS, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity…

7 months ago

DentPrime Announces Comprehensive Dental Care Services in Turkey

LONDON, UK / ACCESSWIRE / February 2, 2024 / DentPrime Health Tourism Agency, a leading health tourism agency accredited by…

7 months ago

Akanda Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

London, United Kingdom--(Newsfile Corp. - February 2, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical…

7 months ago

cbdMD Announces Financing of $1,250,000

Charlotte, North Carolina--(Newsfile Corp. - February 2, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company"), a…

7 months ago

Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

STONY BROOK, NY / ACCESSWIRE / February 2, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in…

7 months ago

FendX Technologies Announces Closing of Non-Brokered Private Placement with Strategic Investors and Upsizing

Oakville, Ontario--(Newsfile Corp. - February 2, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or…

7 months ago

Arrigo Medical Devices Exhibits Innovative Medical Solutions at MD&M West 2024

Arrigo Medical Devices is set to showcase its latest advancements in healthcare technology and device manufacturing at MD&M West 2024.ANAHEIM,…

7 months ago

Akanda Corp. Provides Update on Scheduling Policy in US Aims to Be Among First International Movers in US Pending Approval

London, United Kingdom--(Newsfile Corp. - February 2, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical…

7 months ago